doi: 10.1257/jep.29.1.139.
Pricing in the Market for Anticancer Drugs
Affiliations
- PMID: 28441702
- DOI: 10.1257/jep.29.1.139
Item in Clipboard
Pricing in the Market for Anticancer Drugs
J Econ Perspect.
2015.
No abstract available
Similar articles
-
Market spiral pricing of cancer drugs.Cancer. 2013 Nov 15;119(22):3900-2. doi: 10.1002/cncr.28321. Epub 2013 Sep 3. Cancer. 2013. PMID: 24002792 No abstract available.
-
Economic grand rounds: potential effects of the new medicare drug benefit on pricing for psychotropic medications.Psychiatr Serv. 2005 Sep;56(9):1056-8. doi: 10.1176/appi.ps.56.9.1056. Psychiatr Serv. 2005. PMID: 16148317 Free PMC article. No abstract available.
-
Indication-specific Drug Pricing - Simple in Theory, Complex in Reality.Manag Care. 2018 May;27(5):23-25. Manag Care. 2018. PMID: 29763404
-
Market Access Agreements for pharmaceuticals in Europe: diversity of approaches and underlying concepts.BMC Health Serv Res. 2011 Oct 8;11:259. doi: 10.1186/1472-6963-11-259. BMC Health Serv Res. 2011. PMID: 21982545 Free PMC article. Review.
-
Why are cancer drugs so expensive in the United States, and what are the solutions?Mayo Clin Proc. 2015 Apr;90(4):500-4. doi: 10.1016/j.mayocp.2015.01.014. Epub 2015 Mar 16. Mayo Clin Proc. 2015. PMID: 25792242 Review.
Cited by
-
Levine Cancer Institute Financial Toxicity Tumor Board: A Potential Solution to an Emerging Problem.JCO Oncol Pract. 2021 Oct;17(10):e1433-e1439. doi: 10.1200/OP.21.00124. Epub 2021 Jun 8. JCO Oncol Pract. 2021. PMID: 34101495 Free PMC article.
-
Pairwise association of key lifestyle factors and risk of solid cancers - A prospective pooled multi-cohort register study.Prev Med Rep. 2024 Jan 12;38:102607. doi: 10.1016/j.pmedr.2024.102607. eCollection 2024 Feb. Prev Med Rep. 2024. PMID: 38298822 Free PMC article.
-
Review of Current Policy Strategies to Reduce US Cancer Drug Costs.J Clin Oncol. 2020 Feb 1;38(4):372-379. doi: 10.1200/JCO.19.01628. Epub 2019 Dec 5. J Clin Oncol. 2020. PMID: 31804856 Free PMC article. Review. No abstract available.
-
Cost-Effectiveness of Tumor Genomic Profiling to Guide First-Line Targeted Therapy Selection in Patients With Metastatic Lung Adenocarcinoma.Value Health. 2022 Apr;25(4):582-594. doi: 10.1016/j.jval.2021.09.017. Epub 2021 Nov 1. Value Health. 2022. PMID: 35365302 Free PMC article.
-
Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China.Pharmacoeconomics. 2022 Jul;40(7):715-724. doi: 10.1007/s40273-022-01161-7. Epub 2022 Jun 29. Pharmacoeconomics. 2022. PMID: 35764914 Free PMC article.